Sonrotoclax plus dexamethasone was tolerable and demonstrated antimyeloma activity in patients with relapsed/refractory multiple myeloma harboring t(11;14) Meeting Abstract
| Authors: | Costa, A.; Dhakal, B.; Hultcrantz, M.; Bal, S.; Chuah, H.; Kaufman, J. L.; Kazandjian, D.; Nathwani, N.; Royle, G.; Sborov, D. W.; Venner, C. P.; Cheng, H.; Idoine, A.; Agarwal, A.; Quach, H. |
| Abstract Title: | Sonrotoclax plus dexamethasone was tolerable and demonstrated antimyeloma activity in patients with relapsed/refractory multiple myeloma harboring t(11;14) |
| Meeting Title: | 21st Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 24 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sep 25-28 |
| Meeting Location: | Rio de Janeiro, Brazil |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | S36 |
| End Page: | S37 |
| Language: | English |
| ACCESSION: | WOS:001325737900059 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(24)01899-8 |
| Notes: | Meeting Abstract: OA-58 -- Source: Wos |
